Antisense oligonucleotides (ODN) against SMAD7 and uses thereof in medical field
Abstract:
The invention relates to antisense oligonucleotidic sequences (ODN) against Smad7 suitably modified, and their uses in medical field as therapeutic biological agents, in particular in the treatment of chronic inflammatory bowel disease, such as Crohn's disease and ulcerative colitis.
Information query
Patent Agency Ranking
0/0